Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
3 studies found for:    21527519 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Macitentan in Pulmonary Hypertension of Sickle Cell Disease
Conditions: Pulmonary Hypertension;   Sickle Cell Disease
Intervention: Drug: macitentan
2 Recruiting Sickle Cell Disease Biofluid Chip Technology (SCD BioChip)
Condition: Sickle Cell Disease
Intervention: Other: SCD Group
3 Terminated
Has Results
Sildenafil Therapy for Pulmonary Hypertension and Sickle Cell Disease
Conditions: Sickle Cell Disease;   Pulmonary Hypertension
Interventions: Drug: Sildenafil;   Drug: Placebo

Study has passed its completion date and status has not been verified in more than two years.